Reports have shown that the intervention of CypA/CD147 signaling could probably provide a potential therapeutic and drug target for mice inflammatory periapical lesions progression (40), Glioblastoma (41), APE (42), HCMV (43), and so on. This evidence concerns the gene BSG and apparent mineralocorticoid excess.